DoD released over 100 new SBIR/STTR topics on DSIP within hours of the April 13, 2026 reauthorization Here is some information on Public Law No
Enzalutamide (ENZ) is a highly effective antagonist of the androgen receptor used for the treatment of prostate cancer
While TGAs second statement clarified that medicines and biologicals are exempt from the ban, neither notice addressed chemicals other than PFAS
Diabetes Care 44 , 14331442 (2021)
Curr Opin Pharmacol 7:355359 Mokhtari V, Afsharian P, Shahhoseini M, Kalantar SM, Moini A (2017) A review on various uses of N-acetyl cysteine
Diversity in Clinical Trials | Signant Health Sustainability initiatives From reducing waste to optimizing trial logistics, sustainability will gain further momentum in the industry